Additionally, from 8 reported markers reflecting B-cell level in tumor environment, some of them, such as PNOC, FCRL2, CD19, were found to have different degrees of impact on poorer prognosis on overall survival of ccRCC cohort (Supplementary Figure 1A). This evidence concerns the gene FCRL2 and neoplasm.